Q4 2018 Holdings
Filed 2019-02-12 | 4 holdings | $88.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myovant Sciences Ltd. | COM | G637AM102 | $57.0K | 3,474,645 | 64.5% |
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $31.4K | 1,558,426 | 35.5% |